Are you living with neurogenic overactive bladder problems due to multiple sclerosis? Then you may be eligible to take part in the DIGNITY 2 study. The DIGNITY 2 study is a global medical research study of a new investigational dosage of an approved medication to control urinary incontinence (leakage) as a result of the overactive bladder problems that can occur in people with multiple sclerosis. The aim of the DIGNITY 2 study is to test whether this new dose is also effective at reducing urinary leakage, and to evaluate the side effects related to this new dose.
Overactive bladder is a condition that increases the urgency and frequency of urination, and may sometimes cause urinary incontinence or leakage. Neurogenic bladder is a condition in which there is a loss of normal bladder function caused by a disease or damage to part of the nervous system (e.g. multiple sclerosis). This damage can cause the bladder to become overactive (sometimes referred to as neurogenic overactive bladder), which results in uncontrolled urinary leakage. For those with multiple sclerosis suffering from bladder control problems it can be frustrating, embarrassing and can affect their quality of life.
If you suffer from urinary leakage due to multiple sclerosis (MS) and you have not had satisfactory relief from your symptoms using oral medications (anticholinergics), please continue to navigate through this website to find out more about the condition, treatment options and possible participation in medical research, such as the DIGNITY 2 study.